. Author manuscript; available in PMC: 2013 Sep 21.

Published in final edited form as: Biochem Biophys Res Commun. 2012 Aug 22;426(2):237–241. doi: 10.1016/j.bbrc.2012.08.073

Table 1.

Summary of arrhythmic events

	N	VT(%)	VF(%)	Recovery of APD₉₀ (%)
Control	11	80	70	65
ε-PKC agonist ψ εRACK	8	64	50	100
ε-PKC antagonist εV1	8	100	80	40
Scrambled ε-PKC agonist ψ εRACK	6	85	65	60
Scrambled ε-PKC antagonist εV1	4	90	70	80
TAT-vehicle	4	75	70	70

VT: Ventricular Tachycardia; VF: Ventricular Fibrillation; APD₉₀: Action Potential Duration at 90% repolarization